There’s no shortage of technically impressive AI applications for primary care. Yet these tools tend to lag well behind AI models aimed at clinical specialties when it comes to integration into routine practice.

Two lots of breathing circuits manufactured by Hamilton Medical have a defect that could cause the tubing to splinter. The affected devices must be quarantined, as they cannot be safely used on patients.

Four nursing homes operated by ProMedica Health System are alleged to have failed to adequately feed patients, treat wounds and keep patients clean. The DOJ said the facilities falsified records to cover their tracks.

In an open letter published in the New York Times, former CDC directors call on Congress to mitigate threats to public health caused by mass layoffs and cuts to critical programs. 

The Varipulse PFA platform, which has already received FDA and CE mark approval, was linked to an adverse event rate of just 0.6%. 

New data out of ESC Congress 2025 suggest care teams can take a more minimalist approach during a majority of TAVR cases and only treat patients with local anesthesia. In some cases, however, sedation will still be necessary. 

Leqembi (lecanemab) was approved by the FDA in 2023. It is an infusion drug that has been shown to reduce Alzheimer’s-related cognitive decline by up to 27%. 

A new analysis published in Artificial Intelligence in Medicine argues that education tools are failing to show clinicians how to make use of new technologies, calling into question the benefit of rapid adoption.